Seeking optimal management for radioactive iodine therapy-induced adverse effects
Radioactive iodine therapy (RAIT) is one of the important treatment modalities in the management of differentiated thyroid cancer (DTC). RAIT with iodine-131 has long been used in the management of DTC for the ablation of residual thyroid or treatment of its metastases. Despite being reasonably safe...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Asia-Pacific Journal of Oncology Nursing |
Subjects: | |
Online Access: | http://www.apjon.org/article.asp?issn=2347-5625;year=2017;volume=4;issue=4;spage=319;epage=322;aulast=Charalambous |